New Insights into the Management of Giant Cell Arteritis
FDA Approves Rituximab for Children with GPA & MPA
Race May Not Be a Risk Factor for Giant Cell Arteritis
Stay the Course: How to Maintain Remission in Vasculitis
Large-Vessel Involvement Is an Independent Risk Factor Predicting GCA Mortality
Trial Data Reveals the Limitations of Steroids in Giant Cell Arteritis Therapy
